Crinetics Pharmaceuticals Inc (CRNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CRNX | AMRX | NAMS | ||
| Company | Crinetics Pharmaceuticals Inc | Amneal Pharmaceuticals Inc | Newamsterdam Pharma Company N.V. | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 40.00 | 13.47 | 34.10 | ||
| High | 41.33 | 13.92 | 34.96 | ||
| Low | 39.71 | 13.34 | 33.57 | ||
| Latest | 41.00 | 13.91 | 34.68 | ||
| Change | +1.98 | +0.82 | +1.48 | ||
| % Change | +5.07% | +6.26% | +4.46% | ||
| Volume | 1,102,000 | 1,854,500 | 649,100 | ||
| 20-Day Average Volume | 1,159,790 | 1,746,235 | 832,140 | ||
| Previous Close | 39.02 | 13.09 | 33.20 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 37.44 | 12.51 | 32.64 | ||
| 20-Day Raw Stochastic | 96.05% | 99.55% | 74.12% | ||
| 20-Day Relative Strength | 54.64 | 61.40 | 55.19 | ||
| Weighted Alpha | +9.03 | +82.82 | +80.23 | ||
| Today's Opinion | 24% Sell | 64% Buy | 40% Buy | ||
| Previous Opinion | 64% Sell | 40% Buy | 8% Buy | ||
| Last Month's Opinion | 24% Sell | 24% Buy | 40% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.96% since 04/10/26 | +10.93% since 04/10/26 | -0.23% since 04/10/26 | ||
| Low | 38.25 on 04/13/26 | 12.30 on 04/13/26 | 32.87 on 04/16/26 | ||
| High | 41.33 on 04/17/26 | 13.92 on 04/17/26 | 36.73 on 04/14/26 | ||
| 1-Month | |||||
| %Chg | +8.21% since 03/17/26 | +11.91% since 03/17/26 | +13.33% since 03/17/26 | ||
| Low | 33.10 on 03/30/26 | 11.71 on 03/24/26 | 28.81 on 03/23/26 | ||
| High | 41.33 on 04/17/26 | 13.92 on 04/17/26 | 36.73 on 04/14/26 | ||
| 3-Month | |||||
| %Chg | -26.77% since 01/16/26 | +3.73% since 01/16/26 | +9.57% since 01/16/26 | ||
| Low | 33.10 on 03/30/26 | 11.71 on 03/24/26 | 28.53 on 03/13/26 | ||
| High | 56.99 on 01/21/26 | 15.42 on 02/17/26 | 37.76 on 02/18/26 | ||
| 6-Month | |||||
| %Chg | -1.37% since 10/17/25 | +40.22% since 10/17/25 | -4.73% since 10/17/25 | ||
| Low | 33.10 on 03/30/26 | 9.92 on 10/20/25 | 28.53 on 03/13/26 | ||
| High | 57.99 on 01/05/26 | 15.42 on 02/17/26 | 42.00 on 11/26/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 4,292,905 | 4,376,490 | 3,987,333 | ||
| Shares Outstanding, K | 104,705 | 314,629 | 114,975 | ||
| Annual Sales | 7,700,000 | 3,018,760,000 | 22,500,000 | ||
| Annual Net Income | -465,320,000 | 72,060,000 | -203,820,000 | ||
| Last Quarter Sales | 6,160,000 | 814,320,000 | 30,000 | ||
| Last Quarter Net Income | -122,820,000 | 35,080,000 | -74,920,000 | ||
| 60-Month Beta | 0.30 | 1.32 | 0.13 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.29 on 02/26/26 | 0.21 on 02/27/26 | -0.63 on 02/18/26 | ||
| Latest Earnings Date | 05/07/26 | 05/01/26 | 05/14/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.22 | 0.00 | ||